Worth reading
64In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
6.5
%Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)2024年9月1日〜2025年2月28日ConsolidatedJapanese GAAPNet Sales14,810¥ millionYear on year +6.5%
Operating profit4,172¥ millionYear on year -0.6%
Ordinary income4,277¥ millionYear on year -6.0%
Net income attributable to owners of the parent2,940¥ millionYear on year -7.9%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Financial position at period-end
Total assets58,336¥ million
of which net assets 53,412 ¥ million
The shaded area represents net assets as a proportion of total assets. It is calculated from the two amounts reported by the company.
Cash inflows and outflows
Operating+3,005
Investment-4,579
Financials-2,292
Net change-3,866
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥17,485 million
Segment revenueSurgical-related products ¥4,718 million (YoY +24.6%), Ailess needle-related products ¥5,556 million (YoY +11.7%), Dental Products ¥4,535 million (YoY -11.9%)
Segment profitSurgical-related products ¥1,643 million (YoY +32.1%), Ailess needle-related products ¥2,068 million (YoY +8.1%), Dental Products ¥460 million (YoY -55.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net SalesNot disclosed
Operating profitNot disclosed
Ordinary incomeNot disclosed
Net incomeNot disclosed
Remarks2024年10月7日公表値から現時点で変更なし
Revision to Earnings ForecastNo change
Factors Behind Changes in Business Performance
サージカル関連製品は欧州、中国を中心としたアジア、北米で需要が拡大し、アイレス針関連製品は中南米等のその他地域や中国を中心としたアジアで受注・販売が増加した。デンタル関連製品は中国市場の減速やダイヤバー自主出荷停止で減少し、決算賞与、人件費、販売子会社の販売費及び一般管理費の増加などで利益が減少した。
Disclosure regarding the going concern assumption
Not applicable.
Material subsequent events中国の製品登録情報の記載不備を理由に、「マニーダイヤバー」の自主回収を決議・実施している。約50％の品目は変更申請が認証されるまで販売を停止し、業績への影響は現在精査中としている。
Breakdown of extraordinary income (loss)Gain on sale of non-current assets ¥10 million, Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥13 million, Other ¥3 million
Depreciation and amortization¥1,187 million
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年9月1日〜2025年2月28日 |
| Net Sales | ¥14,810 million (YoY +6.5%) |
| Operating profit | ¥4,172 million (YoY -0.6%) |
| Ordinary income | ¥4,277 million (YoY -6.0%) |
| Profit attributable to owners of the parent | ¥2,940 million (YoY -7.9%) |
| Total assets | ¥58,336 million |
| Net assets | ¥53,412 million |
| Cash flows from operating activities | ¥3,005 million |
| Cash flows from investing activities | ¥-4,579 million |
| Cash flows from financing activities | ¥-2,292 million |
| Cash and cash equivalents at end of period | ¥17,485 million |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit Not disclosed / Ordinary income Not disclosed / Net income Not disclosed / Remarks 2024年10月7日公表値から現時点で変更なし |
| Revision to Earnings Forecast | No change |
| Segment revenue | Surgical-related products ¥4,718 million (YoY +24.6%), Ailess needle-related products ¥5,556 million (YoY +11.7%), Dental Products ¥4,535 million (YoY -11.9%) |
| Segment profit | Surgical-related products ¥1,643 million (YoY +32.1%), Ailess needle-related products ¥2,068 million (YoY +8.1%), Dental Products ¥460 million (YoY -55.8%) |
| Depreciation and amortization | ¥1,187 million |
| Breakdown of extraordinary income (loss) | Gain on sale of non-current assets ¥10 million, Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥13 million, Other ¥3 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Material subsequent events | 中国の製品登録情報の記載不備を理由に、「マニーダイヤバー」の自主回収を決議・実施している。約50％の品目は変更申請が認証されるまで販売を停止し、業績への影響は現在精査中としている。 |
| Factors Behind Changes in Business Performance | サージカル関連製品は欧州、中国を中心としたアジア、北米で需要が拡大し、アイレス針関連製品は中南米等のその他地域や中国を中心としたアジアで受注・販売が増加した。デンタル関連製品は中国市場の減速やダイヤバー自主出荷停止で減少し、決算賞与、人件費、販売子会社の販売費及び一般管理費の増加などで利益が減少した。 |
Items this document does not state (15)
Net income per shareOperating MarginEquity ratioAnnual Dividend ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossChange in accounting policyChanges in the scope of consolidationAvailability of Supplementary Financial Results MaterialsAvailability of Financial Results BriefingIssued Shares at Period-EndTreasury Shares at Period-End
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.サージカル関連製品は欧州、中国を中心としたアジア、北米で販売が好調に推移し、アイレス針関連製品も中南米等のその他地域や中国を中心としたアジアで販売・受注が増加した。一方、デンタル関連製品は中国市場の減速やダイヤバー自主出荷停止の影響で低調となった。営業利益は、前期業績に伴う決算賞与、本社の人員数増加による人件費増加、為替差益の縮小により減少した。自主回収は中国の製品登録情報の記載不備が理由で、業績への影響は現在精査中としている。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.